Journal article Open Access

Has retinal gene therapy come of age? From bench to bedside and back to bench

Trapani, Ivana; Auricchio, Alberto

Abstract

Retinal gene therapy has advanced considerably in the past three decades. Initial efforts have been devoted to comprehensively explore and optimize the transduction abilities of gene delivery vectors, define the appropriate intraocular administration routes and obtain evidence of efficacy in animal models of inherited retinal diseases (IRDs). Successful translation in clinical trials of the initial promising proof-of-concept studies led to the important milestone of the first approved product for retinal gene therapy in both US and Europe. The unprecedented clinical development observed during the last decade in the field is however highlighting new challenges that will need to be overcome to bring gene therapy to fruition to a larger patient population within and beyond the realm of IRDs.

Files (792.2 kB)
Name Size
Trapani and Auricchio 2019.pdf
md5:d5e74f97bbe3c586946eff9ee6198284
792.2 kB Download
44
20
views
downloads
Views 44
Downloads 20
Data volume 15.8 MB
Unique views 37
Unique downloads 20

Share

Cite as